UT Health San Antonio researchers discover how Vitamin B12 can protect against infections
June 9, 2022
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered how Vitamin B12 (VB12) can play an integral role in the regulation of host intestinal homeostasis, shaping the gut microbiome health a …
$10 million from Bexar County to assist School of Public Health development
June 9, 2022
UT Health San Antonio, UTSA collaborate to reduce health disparities, train public health professionals Contact: Will Sansom, UT Health San Antonio, 210-567-2579, sansom@uthscsa.edu Joe Izbrand, UTSA, 210-458-8754, joe.izbrand@utsa.edu SAN ANTONIO (Jun …
KSAT 12: Reports of melatonin exposure rising rapidly in young children in Bexar County, data shows
June 9, 2022
Dr. Shawn Varney, Emergency Medicine/South Texas Poison Center, is quoted in this story. Read More
San Antonio Express-News: UTSA awards $4 million to Alzheimer’s researchers around the world
June 9, 2022
Dr. Bess Frost, Cell Systems and Anatomy/Barshop and Biggs institutes, is quoted in this article. Read More
Genetic Engineering & Biotechnology News: Alzheimer’s Pathology Could Benefit from Activating Microglial Targets of Rapamycin
June 9, 2022
Newly released research by Dr. Manzoor Bhat, Dr. Qian Shi and colleagues in the Department of Cellular and Integrative Physiology is featured in this article. Read More
FOX 29: Several new projects will come underway for medical care and education
June 9, 2022
This story features the partnership between UT Health San Antonio and UTSA and the public health projects in the works for the medical center area. Read More
Healio: Momelotinib superior to danzol in symptomatic and anemic myelofibrosis
June 9, 2022
Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. Read More
Texas Public Radio: Family matters in childhood type 2 diabetes
June 9, 2022
Dr. Jane Lynch, Pediatric Endocrinology, is quoted in this article. Read More
Rapamycin increases Alzheimer’s-associated plaques in mice, study finds
June 7, 2022
The research also reveals a novel way to decrease the plaques. This is a potential drug target. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (June 7, 2022) — Researchers from The University of Texas Health Science Center at San …
Oral pill improves care of patients with bone marrow cancer: Study
June 7, 2022
Results of MOMENTUM myelofibrosis clinical trial presented at ASCO 2022 Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu CHICAGO AND SAN ANTONIO (June 7, 2022) — Momelotinib, an oral pill taken once a day, significantly improved outcomes of patie …